# ANHYDROUS LACTOSE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2023193
Categories: beauty, cleaning, food, industrial, pharma
Functions: Flavouring and nutrient, Fragrance, Humectant, Lubricating agent, Oxidizing agent, Processing aids not otherwise specified, Softener and conditioner, Solvent, Surfactant (surface active agent), Thickening agent
Identifier: DTXSID2023193

> ANHYDROUS LACTOSE is used as flavouring and nutrient / fragrance. EPA CPDat observed this chemical in 180 composition records across product categories including Food and drug, Laboratory supplies, Pet and animal care. Assessed from 26 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 180 composition records across product categories including Food and drug, Laboratory supplies, Pet and animal care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 180 composition records across product categories including Food and drug, Laboratory supplies, Pet and animal care. EPA CPDat classifies this chemical for functional uses including Humectant, Softener and conditioner, Fragrance.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 48 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 25 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 25 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 375 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 2490 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 360 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 869 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 3025 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 469 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 15.69 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1800 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 2850 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 504 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 1083 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 529 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 2906 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 316 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 15 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 410 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 128 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._